A Phase II Study of GC101 in NSCLC

Clinical trial NCT07560111 · RECRUITING

Trial details

NCT number: NCT07560111
Sponsor: Shanghai Juncell Therapeutics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2026-06-01
Primary completion: 2027-06-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.